Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma-B5 (PCDHGB5) is a neural cadherin-like, calcium-dependent cell adhesion protein that is part of the protocadherin gamma gene cluster on chromosome 5[1][2][6]. This gene cluster is thought to play a pivotal role in forming and maintaining specific cell-cell connections in the brain, particularly involved in neuronal connectivity. The protein contains six extracellular cadherin domains, a transmembrane region, and a shared cytoplasmic domain (with other gamma cluster members) involved in intracellular signaling. Although it has important roles in brain development and function, there is currently no evidence that it serves as a direct therapeutic target, is associated with drug interactions, or is used as a biomarker or for patient selection[1][5][6]. Diseases linked to mutations in PCDHGB5 include certain neurodevelopmental disorders and digenic forms of facioscapulohumeral muscular dystrophy[1].
Not applicable; no known drugs target this protein
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma-B5 (PCDHGB5).